12-132926130-T-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_183238.4(ZNF605):āc.1169A>Cā(p.Glu390Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00212 in 1,614,242 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_183238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF605 | NM_183238.4 | c.1169A>C | p.Glu390Ala | missense_variant | 5/5 | ENST00000360187.9 | NP_899061.1 | |
ZNF605 | NM_001164715.2 | c.1262A>C | p.Glu421Ala | missense_variant | 5/5 | NP_001158187.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF605 | ENST00000360187.9 | c.1169A>C | p.Glu390Ala | missense_variant | 5/5 | 1 | NM_183238.4 | ENSP00000353314 | ||
ZNF605 | ENST00000392321.3 | c.1262A>C | p.Glu421Ala | missense_variant | 5/5 | 2 | ENSP00000376135 | P1 | ||
CHFR | ENST00000536932.5 | c.-252+19491A>C | intron_variant | 4 | ENSP00000475247 |
Frequencies
GnomAD3 genomes AF: 0.00279 AC: 424AN: 152236Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.00424 AC: 184AN: 43392Hom.: 4 AF XY: 0.00453 AC XY: 101AN XY: 22320
GnomAD4 exome AF: 0.00205 AC: 3001AN: 1461888Hom.: 40 Cov.: 32 AF XY: 0.00204 AC XY: 1484AN XY: 727246
GnomAD4 genome AF: 0.00279 AC: 425AN: 152354Hom.: 3 Cov.: 33 AF XY: 0.00424 AC XY: 316AN XY: 74502
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at